Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Arglabin

Home DrugsArglabin

Arglabin

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

METHOD FOR PRODUCTION OF HYDROCHLORIDE 1(10) BETA-EPOXY-13-DIMETHYLAMINO-5,7ALPHA,6,11BETA (H)-GUAIA-3(4)-EN-6,12-OLIDE, THE LYOPHILIZED ANTITUMOR PREPARATION 'ARGLABIN'
Applicant: ADEKENOV SERGAZY MYNZHASAROVICHPriority: 2006
US
Arglabin的制备方法
Applicant: 天津尚德药缘科技有限公司Priority: 2012
CN
Medicine preparation for treating brain diseases
Applicant: UNIV WENZHOU MEDICALPriority: 2015
CN
Deuterated arglabin dimethylamine fumarate and preparation method thereof, and application of deuterated dimethylamine fumarate to drug preparation
Applicant: ACCENDATECH CO LTDPriority: 2016
CN
Application of arglabin in preparation of drugs for Stargardt disease
Applicant: UNIV XIAMENPriority: 2018
CN
愈创木烷倍半萜二聚体的制备方法
Applicant: 中国科学院昆明植物研究所Priority: 2021
CN
Application of arglabin in preparation of medicine for treating or preventing diabetic nephropathy and extraction method of arglabin
Applicant: UNIV DALIAN MINZUPriority: 2022
CN
Application of sesquiterpenoids in whitening
Applicant: GUANGZHOU UNIASIA COSMETICS TECH CO LTDPriority: 2024
CN
Application of arglabin in preventing, relieving or/and treating sepsis cardiomyopathy
Applicant: FIRST AFFILIATED HOSPITAL ZHENGZHOU UNIVPriority: 2024
CN
Application of arglabin in preparation of medicine for treating lipopolysaccharide-induced acute lung injury
Applicant: BEIJING CHAO YANG HOSPITAL CAPITAL MEDICAL UNIVPriority: 2024
CN